• Publications
  • Influence
A randomized trial of exercise on well-being and function following breast cancer surgery: the RESTORE trial
ObjectivesThis study aimed to determine the effect of a moderate, tailored exercise program on health-related quality of life, physical function, and arm volume in women receiving treatment forExpand
  • 66
  • 6
Elevation of serum riboflavin carrier protein in breast cancer.
Presently available tumor markers have had a limited clinical impact. Riboflavin carrier protein (RCP) is an estrogen inducible protein that occupies a key position in riboflavin metabolism. BecauseExpand
  • 35
  • 3
Exercise intervention in breast cancer patients with aromatase inhibitor-associated arthralgia: a pilot study.
Aromatase inhibitors (AIs) block estrogen synthesis and are commonly used as adjuvant treatments for breast cancer patients. A common side effect is joint pain. This was a pilot study to examineExpand
  • 26
  • 3
Abdominal pain and colonic obstruction from an intra-abdominal desmoid tumor.
Desmoid tumors are rare, benign, slow-growing, fibroblastic neoplasms that originate from musculoaponeurotic and fascial structures throughout the body. These tumors do not have the ability toExpand
  • 12
  • 3
A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer
PurposeThere is a need for chemotherapy regimens active against anthracycline- and taxane-refractory breast cancer. Data from preclinical and pilot studies performed at Roswell Park Cancer InstituteExpand
  • 8
  • 2
Phase II Trial of Induction Gemcitabine/CPT-11 Followed by a Twice-Weekly Infusion of Gemcitabine and Concurrent External Beam Radiation for the Treatment of Locally Advanced Pancreatic Cancer
Purpose:This phase II trial of induction irinotecan/gemcitabine followed by twice-weekly gemcitabine and upper abdominal radiation was initiated to determine the activity of this regimen in patientsExpand
  • 43
  • 1
Determination of qualitative telomerase activity as an adjunct to the diagnosis of pancreatic adenocarcinoma by EUS-guided fine-needle aspiration.
BACKGROUND Telomerase activity is up-regulated in pancreatic cancer. Hence, measurement of telomerase activity in pancreatic needle-biopsy specimens could assist in establishing a positive diagnosisExpand
  • 51
  • 1
Elevation of serum riboflavin carrier protein in hepatocellular carcinoma.
Early detection of hepatocellular cancer (HCC), makes it surgically resectable with a potential for cure. The test most commonly used to detect HCC is the measurement of serum alpha-fetoprotein (AFP)Expand
  • 14
  • 1
Phase I study of paclitaxel and carboplatin: implications for trials in head and neck cancer.
An ongoing phase I and pharmacokinetic trial of paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) in combination with carboplatin is evaluating the maximum tolerated dose (MTD) of aExpand
  • 6
Irinotecan/gemcitabine followed by twice-weekly gemcitabine/radiation in locally advanced pancreatic cancer.
Early clinical studies combining irinotecan (CPT-11, Camptosar) and gemcitabine (Gemzar) have yielded encouraging results. Gemcitabine administered via a twice-weekly schedule results in an enhancedExpand
  • 9